Catalent Pharma Solutions

George L. Fotiades has been appointed interim president and chief executive officer of Catalent Pharma Solutions, effective immediately. John W. Lowry, the incumbent in this role, is leaving Catalent to pursue other opportunities. The search for Mr. Lowry’s replacement is ongoing.

Mr. Fotiades has served as chairman since Catalent’s creation in 2007 and will continue to serve in that capacity. He brings strong experience to this role, having led the business from 2000 through 2004. Mr. Lowry will  assist Mr. Fotiades during the leadership transition.

Mr Fotiades said, “I would like to recognize John Lowry’s important contributions to Catalent over the last seven years, and particularly the leadership continuity and focus he brought during our transition to a standalone company. I am also pleased to assume an even more active role during this transition to help drive Catalent’s future success.”